SCHEMBL5471069

SCHEMBL5471069

COc1ccccc1NC(=O)Nc1ccc(N2CCN(C(=O)OC(C)(C)C)CC2)nc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
KDM4E B2RXH2 1/20 0.54
USP2 O75604 1/20 0.54
TSHR P16473 1/20 0.54
HSD17B10 Q99714 1/20 0.54
DDB1 Q16531 1/20 0.52
CRBN Q96SW2 1/20 0.52
WNT3A P56704 1/20 0.51
NPC1 O15118 3/20 0.50
MAPT P10636 3/20 0.50
RAB9A P51151 3/20 0.50
AHR P35869 1/20 0.49
EGFR P00533 1/20 0.49
CKS1B P61024 1/20 0.48
SKP1 P63208 1/20 0.48
SKP2 Q13309 1/20 0.48
DGAT1 O75907 1/20 0.48
TRPV1 Q8NER1 1/20 0.48
GPR119 Q8TDV5 1/20 0.48
SMN1; SMN2 Q16637 3/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5453453 0.91 KMT2A (0.54) ALDH1A1KDM4EDDB1CRBNWNT3A
SCHEMBL5459726 0.89 WNT3A (0.51) ALDH1A1KDM4ETSHRDDB1CRBN
SCHEMBL5469390 0.89 WNT3A (0.53) ALDH1A1KDM4ETSHRDDB1CRBN
SCHEMBL5473462 0.89 DGAT1 (0.53) DDB1CRBNWNT3ACKS1BSKP1
SCHEMBL5460059 0.88 MAPT (0.50) ALDH1A1KDM4EDDB1CRBNWNT3A
SCHEMBL5467493 0.87 ALDH1A1 (0.59) ALDH1A1KDM4EUSP2TSHRHSD17B10
SCHEMBL5460804 0.86 MAPT (0.68) ALDH1A1KDM4ETSHRNPC1MAPT
SCHEMBL5462081 0.83 NPY2R (0.62) ALDH1A1KDM4ENPC1MAPTRAB9A
SCHEMBL5458483 0.82 MEN1 (0.59) ALDH1A1KDM4ETSHRNPC1MAPT
SCHEMBL5459843 0.82 RAB9A (0.55) ALDH1A1KDM4EUSP2TSHRHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20070249620-A1 Urea Derivative SANKYO COMPANY, LIMITED (JP) 2007-10-25 US disclosed
EP-1764360-A1 UREA DERIVATIVE Sankyo Company, Limited (JP) 2007-03-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070249620-A1 Urea Derivative UGP2, SLC14A1, DGAT1 ALDH1A1 731/4885KDM4E 2284/4885USP2 460/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.